missing translation for 'onlineSavingsMsg'
Learn More

CD134/OX40 Rabbit anti-Human, Polyclonal, Proteintech

Rabbit Polyclonal Antibody

Brand:  Proteintech 20006-1-AP-20UL

 View more versions of this product

Product Code. 16859494

  • 145.00€ / 20µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Tumor necrosis factor receptor superfamily, member4, also known as ACT35 or CD134 is a cell surface glycoprotein that was discovered through the production of a monoclonal antibody raised against the HUT-102 cell line. It belongs to the tumor necrosis factor receptor superfamily. CD134 was mapped to 1p36 by fluorescence in situ hybridization. CD134 is the primary receptor for feline immunodeficiency virus. CD134 expression can promote viral binding and renders cells permissive for viral entry, productive infection, and syncytium formation. Stimulating the receptor can improve the response to a powerful virus vector and may be useful in vaccine development.
Specifications

Specifications

CD134/OX40
Polyclonal
Unconjugated
TNFRSF4
ACT35, ACT35 antigen, CD134, OX40, OX40L receptor, TNFRSF4, TXGP1L
Rabbit
Antigen Affinity Chromatography
RUO
7293
-20°C
Liquid
Flow Cytometry, Western Blot
0.25 mg/mL
PBS with 50% glycerol and 0.02% sodium azide; pH 7.3
P43489
TNFRSF4
Peptide
20 μL
Primary
Human
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.